Objective-This study aimed to develop a physiologically based pharmacokinetic model for acetone and to predict the kinetic behaviour of acetone in the human body with that model. Methods-The model consists of eight tissue groups in which acetone can be distributed: the mucous layer of the inhaled air tract, the mucous layer of the exhaled air tract, a compartment for gas exchange (alveolus of the lung), a group of blood vessel rich tissues including the brain and heart, a group of tissues including muscles and skin that have low perfusion rates, a group of fatty tissues, an organ for metabolism (liver), and a compartment for urinary excretion (kidney). A mucous layer in the model is only the outermost layer of the mucus lining the wall of the air tract during inhalation and exhalation. To check the relevance of the model, the simulated results were compared with the experimental data. Next, simulation was conducted by changing the volume of the mucous layer and the respiratory rate to clarify the effect of these variables. Finally, simulation of an occupational situation was performed. Results-With an appropriate value for the volume of mucous layer, the simulated acetone concentrations in arterial blood, end exhaled air, urine, and fatty tissue were found to agree well with the experimental data. The volume of mucous layer and rate ofrespiration were critical for the appropriate simulation. The simulated occupational situation fitted the observed regression line in field studies quite well. The simulation also enabled predictions to be made about the characteristic kinetics for water soluble solvents. Conclusion-The model is useful for understanding and explaining the kinetics of acetone.
investigating the kinetic behaviour of organic solvents. Several similar models have been used to describe the kinetics in the human body for styrene,'
I trichloroethylene,4 6 tetrachloroethylene,5 2-butoxyethanol,7 and n-hexane. 8 In a physiologically based pharmacokinetic model, the human body is divided into several tissue groups according to the tissue/blood partition coefficient of the organic solvent, the blood flow rate to the tissue, and the metabolic or excretory role. The solvent is assumed to be distributed according to the partition coefficients. Consequently, the ratio between the solvent concentrations in arterial blood and alveolar air should be equal to the blood/air partition coefficient. This assumption was shown to be appropriate for toluene, trichloroethylene, and methylene chloride in experimental studies. 9 The concentration ratio is, however, much lower than the blood/air partition coefficient for water soluble solvents like acetone and butyl alcohol. 9 For example, the concentration ratio ranges from 15 to 97 despite the blood/air partition coefficient of 245 for acetone. 9 Astrand explained that a water soluble solvent is absorbed in the water of the wet mucous membranes of the respiratory tract and in the saliva during inhalation and then released during exhalation. 9 Dahl et al showed, in a study of dogs, that the nasal uptake of water soluble solvent increased with an increase in the water/air partition coefficient.'0 Consequently, the mucus layer of the respiratory tract plays an important part in the kinetics of water soluble solvents.
Gerde et alII and Morris et al"2 developed physiologically based pharmacokinetic models for the nasal uptake of organic solvents. Johanson constructed a similar model for simulating the uptake of solvent in the wall of the air tract." In his physiologically based pharmacokinetic model, the lung was divided into 18 compartments and the breathing was treated as a cyclic process. Johanson showed that the simulated and the experimentally observed concentrations in the exhaled air agreed. In our paper, we propose a simple model that can describe the kinetic behaviour of acetone in the human body taking into account the uptake in the mucous layer of the respiratory tract.
Methods

DESCRIPTION OF THE MODEL
The body is considered to consist of eight tissue groups in which acetone can be 4 and by Astrand9 respectively.
When air containing acetone is inhaled through the air tract, acetone is partly taken up in the mucous layer of the tract. The acetone concentration in the tract is assumed to be at equilibrium with that in the inhaled air that leaves the tract and reaches the entrance of the alveolus. The acetone concentration in the air that enters the alveolus (if the mucous layer is negligible) is equal to the exposure concentration. When alveolar air is exhaled through the air tract, acetone in the mucous layer of the exhaled air tract is partly released. Astrand.9 The acetone concentration in the mucous layer of the exhaled air tract is also assumed to be at equilibrium to that in the exhaled air that leaves the tract and exits from the nose or mouth. of the mucus as the inhaled and exhaled air tract, the deeper mucous layer and the wall tissue are not taken into account. This is the reason why the instantaneous equilibrium of acetone between the deeper portion of the mucous layer and air may not be achieved due to the rapid and cyclic variation of the acetone concentration caused by cyclic breathing.
In our model, alveolar ventilation is treated as a continuous process. In reality, however, it is a cyclic process of inhalation and exhalation. Accordingly, the mucous layer of the inhaled air tract at the end of inhalation corresponds to that of the exhaled air tract at the start of exhalation and vice versa. Consequently, the mucus in one tract can be hypothetically considered to be exchanged for the other at twice the respiratory rate. Thus the mucus in the tracts can be assumed to circulate between these compartments at the flow rate of 2 x volume of the mucous layer x respiration rate (fig 1) . Although this circulation is an intermittent process, it is described as a continuous process in our model. Respiration rate was selected to be 14 min-' at rest and 18 min-' for a workload of 50 W.13 20 Acetone is metabolised to acetic acid, formic acid, and carbon dioxide in animals and humans.21 22 The organ for metabolism of acetone was assumed to be only the liver in our model. Hallier et al, in a rat study on acetone, reported the Michaelis constant (Km) to be 160 ppm in the atmosphere and the maximum enzymatic reaction rate to be mg/h/kg of body weight.2' The Km value corresponds to 83-5 mg/l in the animal body because the animal/air partition coefficient has been reported to be 220. 21 In this paper, the Km value in humans was assumed to be the same. Because the liver/blood partition coefficient is 0-58,17 the Km value in liver was calculated to be 48-4 mg/l. The maximum enzymatic reaction rate was determined based on the assumption that it is linearly related to the 0-75 power of body weight.
Acetone is assumed to be directly excreted by the kidneys at a rate proportional to the urine/blood partition coefficient. and at 50 W (90 min), which is the scenario of "series 2a".'6 Figures 2 and 3 also present the results for series 2a. The simulated curves were obtained when the volume of the mucous layer was 2-0 ml. Although the simulated concentration of acetone in end exhaled air was about 20% more than that observed during exposure and about 20% less after exposure, the simulated blood and urine concentrations of acetone agreed well with the corresponding observed values. Thus the simulation is considered to be tolerably appropriate. acetone concentrations of end exhaled air at the end of exposure and one minute after are 2 7 to 3 5 in spite of the short interval (one minute) between the two collection times. Figure 6 shows that although the value of end exhaled air at the end of exposure changes rapidly for the first minute after exposure, after this that variable stabilises. Thus the concentration of acetone in end exhaled air one minute after the end of exposure is expected to be a good biological exposure index. The concentration of acetone in exhaled alveolar air almost never changes within 10 minutes after exposure (fig 6) , and thus can be considered to be a good biological exposure index. Figure 10 shows the simulated acetone concentration in urine accumulated in the bladder during the last two hours of exposure and during the last two hours before the next shift. As the simulated urinary curve for the last two hours of exposure is nearly linearly related to exposure, this urinary concentration is expected to be a biological exposure index. There is almost no acetone in the urine in the last two hours before the next shift for exposures of 300 ppm or less, but it increases considerably for exposures of more than 300 ppm. This urinary concentration is not suitable as a biological exposure index because of its non-linearity. Various physiologically based pharmacokinetic models are used in general to describe uptake, distribution, metabolism, and elimination of organic solvents in the human body.'q Most of these models do not take into account the absorption of solvents in the mucous layer of the respiratory tract, although the absorption greatly affects the kinetic behaviour of water soluble solvents. The present physiologically based pharmacokinetic model includes two compartments, the mucous layers of the inhaled and exhaled air tracts, to take this absorption into account. Comparison of the simulated result with the experimental data showed that volume of the mucous layer and the respiration rates play important parts in the appropriate simulation (fig 4) . Respiration rate should be around 14 min-' at rest and around 18 min-' at 50 W according to normal respiratory rates.1320 The best fits in the three simulations resulted from volumes of the mucous layer of 0-6, 2-0, and 1-0 ml, respectively, for series 1, 2a, and 3. Even if the volume of the mucous layer is set at 1 0 ml for series 1 and 2a, the relative errors of the simulation are less than 15% for acetone concentration in arterial blood-for example, at the end of exposure: observed value = 14-8 mg/l v simulated result = 13-7 mg/l in series 1, observed value = 16-9 mg/l v simulated result = 19-2 mg/l in series 2a-and less than 15% for acetone concentration in end exhaled air-for example, at the end of exposure: observed value = 212 ppm v simulated result = 235 ppm in series 1, observed value = 108 ppm v simulated result = 96 ppm in series 2a. As these degrees of error are tolerable for simulation, the volume of mucous layer can be set at about 1 0 ml. 27 Consequently, these factors were not included in our model.
Our model also does not take into account the respiratory dead space. In the actual situation, acetone vapour that reaches the dead space, but not the alveoli, must be partly added to the outer mucous layer. If the added acetone is released during exhalation, the acetone concentration in the end exhaled air may be slightly higher than that in our simulation.
The hepatic clearance of acetone in humans was estimated by extrapolating the data for rats. Such extrapolation may be highly misleading, but adjustments of the volume of the mucous layer until a good fit to the data is obtained can mask an inappropriate value for hepatic clearance. For example, although an overestimated hepatic clearance might lead to a lower acetone concentration in arterial blood, use of a smaller volume of the mucous layer can seemingly correct this result (fig 4) . But such a smaller volume can also lower the acetone concentration in end exhaled air (fig 4) . In our study, both the simulated acetone concentration in arterial blood and that in end exhaled air agreed well with the corresponding observed values. Consequently, the estimated hepatic clearance should not differ greatly from the true value, although it is necessary to evaluate to what extent the model is sensitive to change in clearance.
PREDICTED TIME COURSE OF ACETONE CONCENTRATION IN THE HUMAN BODY For fat soluble solvents like trichloroethylene, their kinetic behaviour in fatty tissue is predicted to differ greatly from those in the other tissues due to the high fat/blood partition coefficient and slow blood flow in fatty tissue.34 But the simulated time course of acetone in fatty tissues was similar to those in the other tissues ( fig 5) . This result is considered to reflect the low fat/blood partition coefficient (0-44).
The concentration of acetone in end exhaled air was expected to rise very rapidly at the start of exposure and decrease at the end of exposure (fig 6) . Such rapid change was confirmed by the experimental study of acetone (figs 2 and 3). This can be explained from the absorption and release of acetone by the mucous layer of the respiratory tract. The reason why the rapid change can be predicted by our physiologically based pharmacokinetic model is that this model includes the outermost layer of the mucus. It does not, however, take into consideration the deeper mucous layer and the wall structure. As stated above, part of the acetone absorbed in the outer mucous layer must slowly diffuse to the deeper portion during exposure, so that the deeper portion would have accumulated acetone at the end of exposure. Consequently, the rapid drop in the concentration of acetone in end exhaled air at the end of exposure may actually be slower than that in the simulation.
The simulation for a week predicted that acetone concentration in arterial blood before the shift would become constant on the fourth and fifth days in the first week even at the highest exposure (fig 7) . This behaviour is different from that for fat soluble solvents. For example, chlorobenzene concentration before the shift is expected to become constant on the fourth and fifth days in the third week.28 This difference is caused by the vastly different fat/blood partition coefficients (chlorobenzene: 86,28 acetone: 0 4417), which make the fatty tissues an accumulator for chlorobenzene but not for acetone.
BIOLOGICAL EXPOSURE INDICES
The concentrations of acetone in the blood at the end of a shift and in the urine for the last two hours of the shift were predicted to be good biological exposure indices. The present simulation was based on the simple exposure scenario (constant exposure concentration and workload) and typical values of physiological variables. In actual workplaces, variation of exposure concentrations within the day, various intensities of workload, and variations between workers in physiological values including hepatic and kidney functions exist, so that the relations between acetone exposure and the biological indices are affected by these variations. Nevertheless, the simulated relation for acetone concentration in the blood at the end of exposure agreed well with the regression line obtained in a field study by Fujino et al29 (fig 8) . Although it differed from the regression line of Mizunuma et al30 (fig  8) , this discrepancy cannot be attributed to any inadequacy of our model considering these stated differences between the simulated situation and the actual one. The simulated line for urinary acetone concentrations in the last two hours of the shift agreed well with the regression line obtained by Mizunuma et al,30 but differed from the regression line of Fujino et al29 (fig 10) . The same considerations that apply to the blood can also apply to urine. It is not clear why the simulated results fit the observed data of Mizunuma et al well for urine but not for blood, but the opposite is true for the observed data of Fujino et al.
The concentration of acetone in exhaled alveolar air was expected to be a good biological exposure index in this simulation, but it is difficult to collect the true air exhaled from the alveoli due to the absorption of acetone by the mucous layer. The concentration of acetone in end exhaled air one minute after exposure was also expected to be a good biological exposure index, and in reality it can be easily collected. Our simulation was conducted, however, on the basis that humans breathe regularly. In general, exhaled air is collected by forced exhalation. The effect of acetone absorption by the mucous layer on the acetone concentration in exhaled air may be lower in forced exhalation than in regular exhalation because the volume of air exhaled from the alveoli becomes much larger, which lowers the effect of the absorption in the mucous layer. Thus the value for forced exhalation can be expected to be between the simulated concentration of exhaled alveolar air and that of end exhaled air one minute after the end of exposure. The regression line obtained in a field study29 meets this consideration ( fig 9) .
Conclusion
We have shown that the simulated acetone concentrations in arterial blood, end exhaled air, fatty tissue, and urine agreed well with the experimental data. In the simulation of the occupational situation, the results fit the data from field studies tolerably well. 
